Відео

Day 2 recap of 5th International hybrid CLL Horizons Conference, a hybrid event 27th - 29th September 2024 in Barcelona, Spain

Day 1 recap of 5th International hybrid CLL Horizons Conference, a hybrid event 27th - 29th September 2024 in Barcelona, Spain

Every 1 September, the global CLL community unites to raise awareness about CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) and give those affected by a diagnosis of CLL a much needed-voice. On World CLL Day we come together to improve understanding of the vulnerability of CLL patients and the challenges involved in living with CLL.

On August 15th, 2024, we hosted a webinar titled ‘Exploring the World CLL Day 2024 Campaign Toolkit: Strategies & Involvement‘. During this webinar, we reviewed the 2024 Campaign Toolkit and discussed how you can participate and utilise the provided assets to create your own campaign. Moderator: Peter Haggert, CLLAN Steering Committee Member, CLL Canada Panelists: Mirna Tomasevic, Jan Rynne and...

The CLL Advocates Network team wants to thank the CLL community for your continuous support and collaboration in amplifying the voices of CLL patients and working together to improve outcomes. Wishing you a joyful holiday season and a New Year filled with peace and prosperity!

DAR AL AMAL is a patient hotel dedicated to cancer patients and their companions who are traveling from villages or cities that are far from the Mohammed VI University Hospital in Marrakech. The center is administered by the non-profil patient organisation AMAL (Association des Malades Atteints de Leucémies) who is a member of the CLL Advocates Network. DAR AL AMAL provides accommodation in ord...

CLL Horizons 2021 Nick York, CLLAN Steering Committee, Chair (UK)

CLL Horizons 2021 Deborah Baker, CLLAN Steering Committee (Canada) Michael Rynne, CLLAN Steering Committee (Ireland)

The CLL Advocates Network team wants to thank the CLL community for your ongoing support and collaboration to raise the voice of CLL patients and together work to improve outcomes! We now wish you happy holidays!

Kathryn Huntley (Steering Committee Member of the CLL Advocates Network, CLLAN) presenting CLLAN´s poster “From Survey to Resource Hub: Chronic Lymphocytic Leukemia (CLL) Global Support Provision” for the 64th annual meeting and exposition of American Society of Hematology (ASH).

On 7 December 2022, CLLAN (CLL Advocates Network) hosted a webinar on "How are advances in Bruton’s tyrosine kinase targeted therapies continuing to change how chronic lymphocytic leukemia (CLL) is treated?". The webinar aimed to explain in an understandable way the basic science behind BTK targeted therapies in use or study today to treat CLL. What different descriptions mean, how treatments w...

On 6 December 2022, CLLAN (CLL Advocates Network) hosted a webinar on "CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs". The webinar explored advances in how CLL patients are treated in the relapsed/refractory setting. What therapies are used for subsequent treatments and what promising new developments may fulfil unmet treatment needs...

On the occasion of World CLL Day 2022 (WCLLD22), CLL patient caregiver Gail from UK shares how her life has been affected since her partner’s diagnosis of chronic lymphocytic leukemia (CLL) and how the COVID-19 pandemic and the lifting of public health measures has affected her family. She explains how pre-exposure Covid-19 treatment helped her husband to get on board and navigate this new land...

On the occasion of World CLL Day 2022 (WCLLD22), CLL patient caregiver Gail from UK shares how her life has been affected since her partner’s diagnosis of chronic lymphocytic leukemia (CLL) and how the COVID-19 pandemic and the lifting of public health measures has affected her family. She explains how pre-exposure Covid-19 treatment helped her husband to get on board and navigate this new land...

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Dr Alina Gerrie (S)

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Dr Alina Gerrie (L)

WCLLD22: Understanding Issues of Dealing with CLL - patient perspective / Marianne (S)

WCLLD22: Understanding Issues of Dealing with CLL - patient perspective / Marianne (L)

WCLLD22: Understanding Issues of Dealing with CLL - the patient perspective / Apendavyo (S)

WCLLD22: Understanding Issues of Dealing with CLL - the patient perspective / Apendavyo (L)

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Prof Paolo Ghia (S)

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Prof Paolo Ghia (L)

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Dr Nicole Lamanna / (S)

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Dr Nicole Lamanna (L)

WCLLD22: Understanding Issues of Dealing with CLL - the patient perspective / Pierre (S)

WCLLD22: Understanding Issues of Dealing with CLL - the patient perspective / Pierre (L)

WCLLD22: Understanding Issues of Dealing with CLL - the patient perspective / Dr Brian Koffman (S)

WCLLD22: Understanding Issues of Dealing with CLL - the patient perspective / Dr Brian Koffman (L)

WCLLD22: Understanding Issues of Dealing with CLL - the HCP perspective / Dr Yervand Hakobyan (S)